PlainRecalls
FDA Drug Low Class III Terminated

Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA

Reported: November 13, 2019 Initiated: November 1, 2019 #D-0306-2020

Product Description

Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA

Reason for Recall

Presence of Foreign substance: identified as a dead ant.

Details

Units Affected
a) 4074 bottles b) 30,300 bottles
Distribution
Product was distributed to major distributors/wholesalers throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA. Recalled by Lupin Pharmaceuticals Inc.. Units affected: a) 4074 bottles b) 30,300 bottles.
Why was this product recalled?
Presence of Foreign substance: identified as a dead ant.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2019. Severity: Low. Recall number: D-0306-2020.